Study S000617
Exenatide Once Weekly for Smoking Cessation: A Randomized Clinical Trial
Registration
Registered primary outcomes
- Number of Participants Who Self-Reported Abstinence and Who Were Biochemically Verified as Abstinent Via Expired CO Level of ≤ 5ppm [6 weeks]
- Post-quit Craving as Assessed by the Questionnaire of Smoking Urges [6 weeks]
- Withdrawal Symptoms as Assessed by the Wisconsin Smoking Withdrawal Scale [6 weeks]
- Cue-induced Craving for Cigarettes Following Virtual Reality Exposure as Assessed by the Questionnaire of Smoking Urges [1 week]
- Cue-induced Craving for Cigarettes Following Virtual Reality Exposure as Assessed by the Questionnaire of Smoking Urges [3 weeks]
Linked records (2)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
| Record | Title | Year | Design | Identifiers | Link basis |
|---|---|---|---|---|---|
| R0008332 | Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial. Yammine L, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco | 2021 | Randomized trial | PMID 33831213DOI | cites ClinicalTrials.gov:NCT02975297; registry reference DERIVED:33831213 |
| R0020868 | Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial. Yammine L, Medicine | 2018 | Protocol | PMID 29480848DOI | registry reference BACKGROUND:29480848 |